Quidel Corporation is a leading manufacturer of diagnostic solutions at the point of care, delivering a continuum of rapid testing technologies that further improve the quality of health care throughout the globe. An innovator for over 40 years in the medical device industry, Quidel pioneered the first FDA-cleared point-of-care test for influenza in 1999 and was the first to market a rapid SARS-CoV-2 antigen test in the U.S. Under trusted brand names, Sofia®, Solana®, Lyra®, Triage® and QuickVue®, Quidel’s comprehensive product portfolio includes tests for a wide range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. With products made in America, Quidel’s mission is to provide patients with immediate and frequent access to highly accurate, affordable testing for the good of our families, our communities and the world.   

Country Pavilion
United States of America
United States
Nature of Business
Healthcare/Medical Travel
Interested to connect with
Clinics/Medical PracticeHealthcare/Medical TravelHospital LaboratoryHospital PrivateHospital Public
Product categories offered
Product sub-categories offered
Drug Abuse TestsIn Vitro Diagnostic TestsIn Vitro Diagnostics Test Kits, CalibratorsMolecular Diagnostic TestsPoint of Care Home TestingPoint of Care Professional DiagnosticsPoint of Care Testing Device
Focus Day
Infectious DiseasesMolecular DiagnosticsPOCT

Social media

Contact details

Country Pavilion